Cryo-Cell International, Inc.

NYSE American CCEL

Cryo-Cell International, Inc. Free Cash Flow for the Trailing 12 Months (TTM) ending August 31, 2024: USD 1.75 M

Cryo-Cell International, Inc. Free Cash Flow is USD 1.75 M for the Trailing 12 Months (TTM) ending August 31, 2024, a -26.05% change year over year. Free cash flow is the amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.
  • Cryo-Cell International, Inc. Free Cash Flow for the Trailing 12 Months (TTM) ending August 31, 2023 was USD 2.37 M, a 124.53% change year over year.
  • Cryo-Cell International, Inc. Free Cash Flow for the Trailing 12 Months (TTM) ending August 31, 2022 was USD -9.67 M, a -482.74% change year over year.
  • Cryo-Cell International, Inc. Free Cash Flow for the Trailing 12 Months (TTM) ending August 31, 2021 was USD 2.53 M, a -58.78% change year over year.
  • Cryo-Cell International, Inc. Free Cash Flow for the Trailing 12 Months (TTM) ending August 31, 2020 was USD 6.13 M, a 13.06% change year over year.
Key data
Date Free Cash Flow Operating Cash Flow Net Cash Used For Investing Activities Net Cash Used Provided By Financing Activities
Market news
Loading...
NYSE American: CCEL

Cryo-Cell International, Inc.

CEO Mr. David I. Portnoy
IPO Date April 4, 1994
Location United States
Headquarters 700 Brooker Creek Boulevard
Employees 82
Sector Health Care
Industries
Description

Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, and kidney disease, ALS, wound healing, and auto-immune diseases. The company also manufactures and sells PrepaCyte CB processing system, a technology used to process umbilical cord blood stem cells. It stores approximately 500,000 cord blood and cord tissue stem cells worldwide. The company markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. Cryo-Cell International, Inc. was incorporated in 1989 and is headquartered in Oldsmar, Florida.

Similar companies

EHC

Encompass Health Corporation

USD 93.06

0.54%

INNV

InnovAge Holding Corp.

USD 3.69

1.93%

SGRY

Surgery Partners, Inc.

USD 19.85

-6.19%

ENSG

The Ensign Group, Inc.

USD 133.50

0.88%

MD

Pediatrix Medical Group, Inc.

USD 13.66

2.63%

PNTG

The Pennant Group, Inc.

USD 26.51

1.07%

SEM

Select Medical Holdings Corporation

USD 18.92

0.64%

DCGO

DocGo Inc.

USD 4.09

1.74%

AIRS

AirSculpt Technologies, Inc.

USD 4.92

2.71%

ACHC

Acadia Healthcare Company, Inc.

USD 44.37

-2.29%

NHC

National HealthCare Corporation

USD 97.73

0.74%

AVAH

Aveanna Healthcare Holdings Inc.

USD 4.51

1.58%

CCM

Concord Medical Services Holdings Limited

USD 4.77

5.76%

SNDA

Sonida Senior Living, Inc.

USD 22.81

3.73%

BKD

Brookdale Senior Living Inc.

USD 4.91

0.20%

StockViz Staff

January 15, 2025

Any question? Send us an email